Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06230510

Milk-Tot Study: Impact of Whole Versus Low-fat Milk on Child Health

In the U.S. it is recommended that children consume whole cow's milk (3.5% fat) from ages 1 to 2 years to support rapid early growth and brain development, and then at age 2 years transition to low-fat (1%) or non-fat milk to reduce saturated fat and calorie intake. To date, few studies have examined the optimal milk type for children to prevent obesity. This randomized controlled trial will evaluate the effect of consumption of whole versus 1% milk on child adiposity.

Recruiting

Interested in participating?

Request Info

Key information

Age range

23 month–48 month

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Nutrition Policy Institute, University of California Agriculture and Natural Resources

Oakland, California, 94607, United States

Location status: Recruiting

Location contact

Kassandra Bacon

CONTACT

[email protected]

510-987-9023

Lorrene Ritchie, PhD

PRINCIPAL_INVESTIGATOR

Ryan Williams

CONTACT

[email protected]

510-987-9023

About this study

The prevalence of child obesity in the U.S. has tripled since the 1970s and excess weight gain - even in young children - is a precursor to adult obesity and associated co-morbidities. In the U.S. it is recommended that children consume whole cow's milk (3.5% fat) from ages 1 to 2 years to support rapid early growth and brain development, and then at age 2 years transition to low-fat (1%) or non-fat milk to reduce saturated fat and calorie intake. However, surprisingly few rigorous trials to support recommendations on optimal milk type have been conducted and existing observational studies paradoxically suggest that lower fat milk consumption is associated with increased adiposity in children. The effects of the types of fat found in milk on cardiometabolic disease risk have also been questioned. This randomized controlled trial will evaluate the effect of consumption of whole versus 1% milk on child adiposity and other health and developmental outcomes beginning after toddlers have successfully transitioned from breastmilk and/or formula to cow's milk at 2 years of age. Investigators will recruit 625 parents of toddlers and randomly assign 625 toddlers to either whole or 1% milk groups for 1 year (with estimated final sample size of 500). Our primary aim is to determine how milk fat type (whole versus 1%) consumed from age 2 to 3 years affects change in adiposity as measured by waist-to-height ratio (primary outcome), body mass index, tri-ponderal mass index, and waist circumference. Secondary aims are to evaluate how milk type consumed from age 2 to 3 years affects changes in milk, total and saturated fat, added sugars, and total energy intake and overall diet quality, as well as blood lipids and vitamin D status, and neurocognitive development. Results from the Milk-TOT Study can help pediatric health care providers give evidence-based dietary recommendations to improve child weight and health, and can inform the types of milk provided to participants in the federal nutrition programs which collectively provide milk to over half of all young children in the U.S.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Parents of children: 1) willing to be randomized to provide either only whole or 1% milk to their child for 1 year, 2) access to a smart phone and a tablet, laptop or computer with internet and email at home, 3) ability to speak and read English or Spanish for the purposes of receiving study communications and completing surveys and dietary assessments (to avoid needing to translate all study materials and have research staff fluent in other languages due to budget limits), 4) not planning to move outside of the San Francisco Bay Area or discontinue being child's primary caregiver for the next year (e.g., foster care, parent separation).

Exclusion criteria

Children: 1) <23 months or >48 months old at recruitment; 2) condition or medication that affects growth or daily feeding, or cardiometabolic health such as hypopituitarism, growth hormone deficiency, inborn error of metabolism, syndromic obesity, familial hypercholesterolemia, 3) weight-for-length or height below the 2nd percentile, 4) lactose intolerance, milk allergy or other dietary restrictions (e.g., vegan) that impact ability to consume dairy or otherwise limit dietary intake, 5) resides in more than one household (e.g., shared care by separated parents), and 6) not covered by public or private medical insurance (may reduce well-child doctor visits). If two eligible children are in a household, one will be randomly selected to participate.

Treatment and study plan

Introduction of Milk Type

Behavioral

Beginning at approximately age 2, milk (equivalent to 2 cups/day) will be provided at no cost to the family for one year.

Child Nutrition Counseling

Behavioral

Parent/caregivers will receive quarterly phone-based counseling by a Registered Dietitian (RD) on how to introduce the toddler to the assigned milk and the importance of continuing to drink the assigned milk for the one year.

Primary outcomes

  1. Change in waist-to-height ratio

    Time frame: Baseline and 12-months after the start of the study.

    Waist-to-height ratios will be calculated using measured height in m and waist circumference in m.

Secondary outcomes

  1. Change in body mass index z-score

    Time frame: Baseline and 12-months after the start of the study.

    BMI z-scores will be determined using measured height in m and weight in kg to calculate kg/m^2, and Centers for Disease Control and Prevention (CDC) growth curves.

  2. Change in tri-ponderal mass index

    Time frame: Baseline and 12-months after the start of the study.

    Try-ponderal mass index (TMI) will be determined using measured height in m and weight in kg to calculate kg/m^3.

  3. Change in waist circumference z-score

    Time frame: Baseline and 12-months after the start of the study.

    Waist circumference z-scores will be determined using measured waist circumference and CDC growth curves.

  4. Change in dietary intake

    Time frame: Baseline and 12-months after the start of the study.

    Energy (kcals/day), milk (cups/day and %kcals), total dairy (cups/day and %kcals), total fat (g/day and %kcals), saturated fat (g/day and %kcals), added sugars (g/day and %kcals) and calcium (mg/day) intake will be measured using 24-hour recalls.

  5. Change in diet quality

    Time frame: Baseline and 12-months after the start of the study.

    Diet quality will be measured using the healthy eating index-2020 from 24-hour recalls.

  6. Change in blood measures

    Time frame: Baseline and 12-months after the start of the study.

    Lipid concentrations, glucoregulatory indices, and 25(OH)D concentrations will be measured in a morning blood draw.

  7. Change in brain growth

    Time frame: Baseline and 12-months after the start of the study.

    Head circumference z-scores will be determined using measured head circumference in cm and CDC growth curves.

  8. Change in neurocognitive development

    Time frame: Baseline and 12-months after the start of the study.

    Cognitive, communication and physical development scores will be determined using the Developmental Assessment of Young Children-2 tool.

Study contacts

Contact information is provided by the study sponsor or research team.

Lorrene Ritchie, PhD

CONTACT

[email protected]

(510) 987-0523

Sponsors and collaborators

Lead sponsor

University of California, Davis

Other

Collaborators

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
  • Stanford University

Registry information

Official study title

Milk Type in Toddlers (Milk-TOT) Study: Impact of Whole Versus Low-fat Milk on Child Adiposity, Health and Development

Important dates

Study start
2024
Primary completion
2027
Study completion
2028
First posted
Jan 30, 2024
Registry last updated
May 18, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.